News
April 2020
Next step towards RNA-based therapy of heart failure: In a collaborative effort, Rabea Hinkel (MRI TUM) and Deepak Ramanujan from the IPT successfully demonstrated the efficacy of synthetic inhibitors of microRNA miR-21 in a pig model for myocardial ischemia. Recapitulating the situation in human patients where, after myocardial infarction, dysregulation of microRNAs contributes to pathologic cardiac hypertrophy and fibrosis, they showed that inhibition of miR-21 significantly ameliorates the phenotype. Their publication in JACC, entitled „AntimiR-21 Prevents Myocardial Dysfunction in a Pig Model of Ischemia/Reperfusion Injury“, was selected as the Paper of the Month by the German center for Cardiovascular Research (DZHK).
October 2019
Congratulations to Anna Patricia Schön for receiving the 1st place of the Otto-Hess poster prize 2019 and to Christina Beck for winning the 1st place Hans-Jürgen-Bretschneider poster prize 2019 awarded by the Deutsche Gesellschaft für Kardiologie.
May 2019
The German Research Foundation funds research into molecular regulation in the cardiovascular system
The German Research foundation has approved funding for a new collaborative research center ("Sonderforschungsbereich", short "SFB") at the behest of the Technical University of Munich (TUM), Goethe University Frankfurt and other partners. Over the next four years, the 30-partner consortium will investigate the role of non-coding RNAs in the cardiovascular system and will receive funding around 11 million euros of this purpose.
www.tum.de/nc/en/about-tum/news/press-releases/details/35465/
May 2019
Otto-Hess scholarship for Paula Uibel
MD student Paula Uibel has been awarded the Otto-Hess scholarship for 2019. The Otto-Hess scholarship awarded by the Deutsche Gesellschaft für Herz- und Kreislaufforschung (DKG) supports excellent MD research projects.
February 2019
Poster prize
Christina Beck won one out of three poster prizes at the 2019 Annual Meeting of the German Society of Pharmacology and Toxicology for her Poster on "Argonaute immunoprecipitation and RNA sequencing to identify the targets of microRNAs-21 and -29 in the mammalian heart".
January 2019
Chair of Pharmacology and Toxicology at Salzburg University for Antonio Sarikas
Antonio Sarikas, group leader at the IPT since 2009 has accepted an offer by the Medical University of Salzburg (Austria) as Chair of Pharmacology and Toxicology. He starts January 2019 and we are actively looking for a successor.
December 2018
DGK Stipend for Karin Ziegler
Karin Ziegler has been awarded the 2018 DGK stipend for her project on "Characerization of the symathetic control of cardiac immune cells".
November 2018
Congratulation to Anna Patricia Schön for receiving the Segnitz-Ackermann prize awarded by the Deutsche Stiftung für Herzforschung!
The award ceremony was at the DGK Basic science meeting in October 2018 in Berlin.
Quelle: "DGK/Stefan Erhard"
February 2018
Postdoc Start-up Grant for Anne Dueck
Anne Dueck won one of the competitive Postdoc startup grants by the DZHK. The grant supports one year of startup funding as a basis for a grant application to one of the major funding insitutions.
April 2017
Congrats to Karin Ziegler on winning the first place of the Otto-Hess-Poster prize! She received the award for the best poster presentation in the Otto-Hess-Poster session at the 83th annual meeting of the German Cardiac Society in Mannheim.
Quelle: "DGK/Thomas Hauss"
- From left to right: Prof. Dr. Hugo A. Katus, Karin Ziegler, Prof. Dr. Martin Borggrefe
Welcome to the TUM Institute of Pharmacology and Toxicology (IPT)!
The IPT is part of the Biederstein Campus at the TUM, located between Munich’s popular district Schwabing and the English Garden. Our fully renovated building hosts a growing 
team of scientists and staff, and provides an ideal research infrastructure with modern lab space and high-end scientific equipment.
As a research institute for translational medicine, we dedicate our work to new therapeutics for cardiovascular diseases, which are still the major cause of death worldwide. Our mission is to identify new drug targets, to analyze their function and to develop novel therapeutic strategies.
This would not be possible without bright minds and scientific exchange. We offer some of the best pharmacology teaching to students, ranging from lectures and award-winning e-learning tools to lab internships, bachelors, masters or PhD theses. The IPT also coordinates the Munich Heart Alliance, a joint effort of clinicians and scientists to improve the development of novel cardiac therapies. This outstanding research community has then been appointed by the German Ministry for Education and Research (BMBF) as partner site of the German Center for Cardiovascular Research (
DZHK). In addition, we maintain productive collaborations with industrial partners.